Bio-Rad Laboratories (BIO) Cash from Investing Activities Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.04% |
| Dec 31, 2025 | 10.56% |
| Sep 30, 2025 | -19.85% |
| Jun 30, 2025 | -5.43% |
| Mar 31, 2025 | 17.43% |
| Dec 31, 2024 | 13.00% |
| Sep 30, 2024 | 12.71% |
| Jun 30, 2024 | -15.44% |
| Mar 31, 2024 | -13.67% |
| Dec 31, 2023 | 27.10% |
| Sep 30, 2023 | 20.28% |
| Jun 30, 2023 | 18.47% |
| Mar 31, 2023 | -30.23% |
| Dec 31, 2022 | -34.95% |
| Sep 30, 2022 | -42.95% |
| Jun 30, 2022 | -31.12% |
| Mar 31, 2022 | -52.69% |
| Dec 31, 2021 | -62.47% |
| Sep 30, 2021 | -8.77% |
| Jun 30, 2021 | -11.01% |
| Mar 31, 2021 | 1.02% |
| Dec 31, 2020 | 6.53% |
| Sep 30, 2020 | 39.78% |
| Jun 30, 2020 | -26.02% |
| Mar 31, 2020 | 15.00% |
| Dec 31, 2019 | -4.36% |
| Sep 30, 2019 | -18.77% |
| Jun 30, 2019 | 23.88% |
| Mar 31, 2019 | 8.58% |
| Dec 31, 2018 | -6.80% |
| Sep 30, 2018 | -16.75% |
| Jun 30, 2018 | -26.11% |
| Mar 31, 2018 | 29.53% |
| Dec 31, 2017 | 26.17% |
| Sep 30, 2017 | 32.27% |
| Jun 30, 2017 | 24.36% |
| Mar 31, 2017 | -5.05% |
| Dec 31, 2016 | 21.90% |
| Sep 30, 2016 | 0.87% |
| Jun 30, 2016 | 5.94% |
| Mar 31, 2016 | 8.03% |
| Dec 31, 2015 | -9.97% |
| Sep 30, 2015 | 14.97% |
| Jun 30, 2015 | -1.29% |
| Mar 31, 2015 | 18.32% |
| Dec 31, 2014 | -16.96% |
| Sep 30, 2014 | 10.85% |